Showing results (1-10 of 142) with videos related to
Sort By:
Pageof 15
Expert Review of Hematology|February 17, 2021
The important role of intensive induction chemotherapy in the treatment of acute myeloid leukemiaTara L Lin, Livio PaganoOncotargets and Therapy|April 14, 2012
Hedgehog pathway as a drug target: Smoothened inhibitors in developmentTara L Lin, William MatsuiCurrent Oncology Reports|May 27, 2004
Adjuvant therapy for resected non-small-cell lung cancer: recent advances, emerging agents, and lingering questionsTara L Lin, Julie R BrahmerClinical Medicine Insights. Oncology|June 2, 2012
Acute myeloid leukemia: focus on novel therapeutic strategiesTara L Lin, M Yair LevyHematology. American Society of Hematology. Education Program|December 9, 2023
The approach of HMA plus VEN with or without BMT for all patients with AMLHeather J Male, Tara L LinThe American Journal of the Medical Sciences|April 28, 2011
Prognostically important molecular markers in cytogenetically normal acute myeloid leukemiaTara L Lin, B Douglas SmithBest Practice & Research. Clinical Haematology|June 18, 2013
NK/T-cell lymphomas in childrenCatherine Lai, Kieron DunleavyJournal of Hematology & Oncology|September 20, 2019
Recent drug approvals for acute myeloid leukemiaCatherine Lai, Kimberley Doucette, Kelly NorsworthyClinical Advances in Hematology & Oncology : H&O|June 22, 2022
Clonal cytopenias of undetermined significance: potential predictor of myeloid malignancies?Nikitha Vobugari, Cambria Heuston, Catherine LaiTherapeutic Advances in Hematology|May 17, 2021
Advances in therapeutic options for newly diagnosed, high-risk AML patientsKimberley Doucette, Judith Karp, Catherine LaiPageof 15